Furthermore, IGFs have been shown to increase survival and proliferation in NB cells, PC cells, and MM cells in vitro, suggesting that IGF-1 released from the bone matrix in the proximity of metastatic tumor cells could also directly benefit tumor progression [156–158] (Fig. 2D). The gene discussed is IGF1; the disease is neuroblastoma.